CAPR Logo

Capricor Therapeutics, Inc. (CAPR) 

NASDAQ
Market Cap
$648.4M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
40 of 963
Rank in Industry
32 of 552

Largest Insider Buys in Sector

CAPR Stock Price History Chart

CAPR Stock Performance

About Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.

Insider Activity of Capricor Therapeutics, Inc.

Over the last 12 months, insiders at Capricor Therapeutics, Inc. have bought $15M and sold $0 worth of Capricor Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Capricor Therapeutics, Inc. have bought $5.02M and sold $474.71M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Nippon Shinyaku Co Ltd (10 percent owner) — $15M.

The last purchase of 2,798,507 shares for transaction amount of $15M was made by Nippon Shinyaku Co Ltd (10 percent owner) on 2024‑09‑20.

List of Insider Buy and Sell Transactions, Capricor Therapeutics, Inc.

2024-09-20Purchase10 percent owner
2.8M
9.1284%
$5.36$15M+268.32%
2023-10-12Purchasedirector
410
0.0015%
$2.75$1,128+63.96%
2023-10-10Purchasedirector
10,000
0.0395%
$2.83$28,300+62.63%
2023-10-09Purchasedirector
5,083
0.02%
$2.82$14,334+66.55%
2023-10-06Purchasedirector
5,000
0.019%
$2.84$14,200+58.10%
2023-10-04Purchasedirector
2,500
0.0095%
$2.90$7,250+61.27%
2023-04-17Sale
14,772
$64,258.00$949.22M+3.50%
2023-03-28Sale
3,000
0.0118%
$4.06$12,180+6.59%
2022-06-29Sale
28,215
0.1163%
$3.77$106,371+19.68%
2022-06-29PurchaseCHIEF BUSINESS OFFICER
1,500
0.0062%
$3.76$5,643+19.68%
2022-06-27Sale
17,775
0.0736%
$4.44$78,921+1.59%
2017-05-09Purchase10 percent owner
2.29M
11.0606%
$3.10$7.1M-46.21%
2017-05-09Purchasedirector
20,000
0.0966%
$3.10$62,000-46.21%
2017-05-09Purchasedirector
50,000
0.2415%
$3.10$155,000-46.21%
2016-09-21Purchase10 percent owner
625,000
3.0673%
$3.20$2M-26.89%
2016-03-16Purchase10 percent owner
833,332
4.8375%
$2.40$2M+29.40%
2016-03-16Purchasedirector
182,738
1.0608%
$2.40$438,571+29.40%
2016-03-16Purchase10 percent owner
833,332
4.8375%
$2.40$2M+29.40%
2016-03-16PurchaseChief Executive Officer
30,456
0.1768%
$2.40$73,094+29.40%
2016-03-16Purchasedirector
200,000
1.161%
$2.40$480,000+29.40%

Insider Historical Profitability

15.38%
Nippon Shinyaku Co Ltd10 percent owner
7090351
15.5935%
$14.2610
CEDARS SINAI MEDICAL CENTER10 percent owner
4049959
8.9069%
$14.2640+25.52%
Marban Eduardo10 percent owner
3173354
6.979%
$14.2620<0.0001%
KASH PETER Mdirector
1596208
3.5105%
$14.2630
TANEN DAVID Mdirector
1520705
3.3444%
$14.2640
GRASMICK LOUIS Jdirector
1059740
2.3306%
$14.2640+8.61%
St. John Edward A.10 percent owner
842439
1.8527%
$14.2620+25.52%
Marban LindaChief Executive Officer
273709
0.602%
$14.2630+1.25%
Manzo Louisdirector
138384
0.3043%
$14.2630+25.52%
BREWER RICHARD BExecutive Chairman
125000
0.2749%
$14.2610
Kazam Joshua Adirector
38084
0.0838%
$14.2690+21.63%
Musket David Bdirector
31536
0.0694%
$14.2652+21.63%
COLLIER EARL M JRdirector
26856
0.0591%
$14.2610
Evans DaronChief Financial Officer
25652
0.0564%
$14.2670
Lieu HsiaoExecutive VP, Clinical Dev.
12600
0.0277%
$14.2620
Krasney KarenEVP, General Counsel
11156
0.0245%
$14.2620+25.52%
Strumph Peter MChief Executive Officer
7580
0.0167%
$14.2630
Auwaerter Paul Gisbertdirector
5000
0.011%
$14.2610
GERSHELL LELANDCHIEF FINANCIAL OFFICER
2100
0.0046%
$14.2610+29.4%
Bergmann AnthonyVice President of Finance
2030
0.0045%
$14.2610+29.4%
SCHAFER GREGORY Wdirector
100
0.0002%
$14.2610
Avat Xavier
0
0%
$14.2611+19.68%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$9.27M4.291.37M+17.2%+$1.36M<0.0001
BlackRock$2.59M1.2381,735+6.13%+$149,801.00<0.0001
Geode Capital Management$2.23M1.03328,477+3.88%+$83,391.31<0.0001
Susquehanna International Group$2.15M0.99316,260+112.09%+$1.13M<0.01
Millennium Management LLC$1.99M0.92293,041+1,292.91%+$1.85M<0.01
Goldman Sachs$1.45M0.67213,169+1,298.75%+$1.34M<0.0001
Advisor Group Holdings Inc$1.07M0.5158,200+35.74%+$282,803.50<0.01
Northern Trust$816,933.000.38120,314-5.43%-$46,952.90<0.0001
State Street$792,556.000.37116,724+36.96%+$213,885.01<0.0001
Morgan Stanley$757,743.000.35111,597+134.01%+$433,941.75<0.0001
Arrowstreet Capital, Limited Partnership$689,000.000.32101,542New+$689,000.00<0.01
Jane Street Capital$629,161.000.2992,660+131.42%+$357,296.36<0.01
JPMorgan Chase$618,454.000.2991,083New+$618,454.00<0.0001
Hrt Financial Llc$560,000.000.2682,557New+$560,000.00<0.01
Wellington Management Company$541,564.000.2579,759New+$541,564.00<0.0001
Citigroup$532,010.000.2578,352+229.24%+$370,421.60<0.0001
Man Group Plc$494,971.000.2372,897New+$494,971.00<0.01
BNY Mellon$480,339.000.2270,742-16.54%-$95,175.59<0.0001
Qube Research & Technologies$471,246.000.2269,403+26.17%+$97,735.18<0.01
Jump Financial Llc$379,650.000.1855,913+5.9%+$21,137.31<0.01
Cubist Systematic Strategies$368,480.000.1754,268New+$368,480.00<0.01
Renaissance Technologies$361,000.000.1753,150-63.68%-$632,826.55<0.01
Walleye Capital$323,516.000.1547,646New+$323,516.00<0.01
LINSCO PRIVATE LEDGER CORP$314,635.000.1546,338-40.77%-$216,600.99<0.0001
Wells Fargo$221,096.000.132,562+13,697.46%+$219,493.56<0.0001
Citadel Advisors LLC$209,152.000.130,803New+$209,152.00<0.0001
Occudo Quantitative Strategies Lp$176,927.000.0826,057New+$176,927.000.03
Simplex Trading Llc$171,000.000.0825,197-41.05%-$119,055.960.01
ExodusPoint Capital Management, LP$167,000.000.0824,570New+$167,000.00<0.01
Two Sigma$162,960.000.0824,000+21.83%+$29,197.00<0.0001
Point72 Asia Singapore Pte Ltd$160,774.000.0723,678New+$160,774.000.02
Bank of America$149,394.000.0722,002-7.27%-$11,719.57<0.0001
Main Street Financial Solutions Llc$135,800.000.0620,000New+$135,800.000.02
Y Intercept Hong Kong Ltd$132,656.000.0619,537+90.36%+$62,970.350.01
Brevan Howard Capital Management Lp$132,188.000.0619,468New+$132,188.000.01
OMERS$122,220.000.0618,000New+$122,220.00<0.01
Charles Schwab$91,522.000.0413,4790%+$0<0.0001
Balyasny Asset Management Llc$88,229.000.0412,994New+$88,229.00<0.0001
Woodline Partners LP$84,610.000.0412,461-98.63%-$6.09M<0.01
Coastal Bridge Advisors Llc$73,970.000.0310,8940%+$00.02
Jefferies Financial Group$71,974.000.0310,600New+$71,974.00<0.01
Prudential Financial$67,900.000.0310,000New+$67,900.00<0.0001
U.S. Bancorp$50,667.000.027,4620%+$0<0.0001
Tower Research Capital$32,816.000.024,833+255.37%+$23,581.62<0.0001
LAZARD ASSET MANAGEMENT LLC$17,000.000.012,693New+$17,000.00<0.0001
UBS$10,185.000.011,500New+$10,185.00<0.0001
Householder Group Estate Retirement Specialist Llc$10,185.000.011,5000%+$0<0.01
Royal Bank of Canada$10,000.00<0.011,400-85.97%-$61,271.43<0.0001
Hightower Advisors$6,000.00<0.01901New+$6,000.00<0.0001
Macquarie Group$6,000.00<0.01941New+$6,000.00<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.